title: Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF.
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Stoll
authors.forename: Bernard G
authors.initials: BG
authors.lastname: Gauthier
authors.forename: Marcela
authors.initials: M
authors.lastname: Vergara
authors.forename: Joseph
authors.initials: J
authors.lastname: Ramek
authors.forename: Rachel
authors.initials: R
authors.lastname: Frank
authors.forename: Howard
authors.initials: H
authors.lastname: Trachtman
mesh_terms: D000328:Adult; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D017706:Lisinopril / Q000627:therapeutic use*; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D011086:Polycythemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D017706:Lisinopril; D019808:Losartan